Caricamento azienda
Just reported
From Health Catalyst's results release of 5 novembre 2026; its quarterly report has since been filed.
Actual
56,3M USD
-26% y/y
-20% q/q
Guided
55,5M USD
midpoint
Actual
0,53 USD
Guided
—
No guide given
Actual
50,1M USD
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Health Catalyst is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
VEEVVeeva Systems Inc.48,9B USDA+
BTSGBrightSpring Health Services, Inc.14,2B USDA
HNGEHinge Health, Inc.9,4B USDA+
HQYHealthequity, Inc.8,6B USDA+
DOCSDoximity, Inc.5,9B USDB+Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 ott 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 ott 2026CAGraded C, now ACostruito dai documenti depositati da Health Catalyst, Inc. presso la Securities and Exchange Commission (SEC), l’autorità di vigilanza statunitense. Le cifre sono quelle dichiarate, con lo storico per azione ricalcolato sulla base azionaria di oggi. Questo descrive un’azienda: non è consulenza finanziaria né una raccomandazione di acquisto o vendita.
Previsione dell’azienda: ricavi di da 246M USD a 249M USD per Esercizio 2026 — in calo del 20,5% sull'anno precedente (311,1M USD)
Grade D
La fascia sotto il prezzo mostra il voto in ogni data, calcolato solo sui documenti già pubblici in quel momento.
Mostra 2 trimestri su 28 dello storico dei voti di Health Catalyst, Inc.. Gli altri 26 risalgono fino a febbraio 2020.
